An Oblon COVID-19 Initiative

April 28, 2020 – Firm News

Oblon is currently waiving its fee for filing a provisional patent application for an invention directly related to address the COVID-19 pandemic. “We are proud to promote our clients’ efforts in addressing this global health crisis.  A number of our clients have taken advantage of this offering, and we hope that their scientific and technological developments will lead to a safer world,” said Managing Partner Philippe Signore, Ph.D.